The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities

Background:  The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored. Methods:  Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and...

Full description

Saved in:
Bibliographic Details
Published inJournal of oral pathology & medicine Vol. 31; no. 2; pp. 109 - 116
Main Authors Hamada, Toshihiro, Ueta, Eisaku, Kodama, Hiroyuki, Osaki, Tokio
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science, Ltd 01.02.2002
Blackwell
Subjects
Online AccessGet full text
ISSN0904-2512
1600-0714
DOI10.1046/j.0904-2512.2001.00015.x

Cover

Abstract Background:  The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored. Methods:  Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high‐performance liquid chromatography, and the relationship between excretion levels and plasma protein‐binding activities of the antibiotics was investigated. Results:  Following addition of 50 µg/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 ± 1.2, 70.8 ± 0.8, 36.2 ± 0.5 and 8.3 ± 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 ± 0.5, 62.1 ± 1.4, 54.0 ± 0.8 and 6.0 ± 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 µg/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs. Conclusion:  These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment.
AbstractList Background:  The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored. Methods:  Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high‐performance liquid chromatography, and the relationship between excretion levels and plasma protein‐binding activities of the antibiotics was investigated. Results:  Following addition of 50 µg/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 ± 1.2, 70.8 ± 0.8, 36.2 ± 0.5 and 8.3 ± 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 ± 0.5, 62.1 ± 1.4, 54.0 ± 0.8 and 6.0 ± 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 µg/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs. Conclusion:  These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment.
The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored.BACKGROUNDThe excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored.Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high-performance liquid chromatography, and the relationship between excretion levels and plasma protein-binding activities of the antibiotics was investigated.METHODSExcretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high-performance liquid chromatography, and the relationship between excretion levels and plasma protein-binding activities of the antibiotics was investigated.Following addition of 50 microgram/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 +/- 1.2, 70.8 +/- 0.8, 36.2 +/- 0.5 and 8.3 +/- 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 +/- 0.5, 62.1 +/- 1.4, 54.0 +/- 0.8 and 6.0 +/- 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 microgram/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs.RESULTSFollowing addition of 50 microgram/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 +/- 1.2, 70.8 +/- 0.8, 36.2 +/- 0.5 and 8.3 +/- 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 +/- 0.5, 62.1 +/- 1.4, 54.0 +/- 0.8 and 6.0 +/- 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 microgram/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs.These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment.CONCLUSIONThese results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment.
The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored. Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high-performance liquid chromatography, and the relationship between excretion levels and plasma protein-binding activities of the antibiotics was investigated. Following addition of 50 microgram/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 +/- 1.2, 70.8 +/- 0.8, 36.2 +/- 0.5 and 8.3 +/- 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 +/- 0.5, 62.1 +/- 1.4, 54.0 +/- 0.8 and 6.0 +/- 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 microgram/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs. These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment.
Author Kodama, Hiroyuki
Hamada, Toshihiro
Osaki, Tokio
Ueta, Eisaku
Author_xml – sequence: 1
  givenname: Toshihiro
  surname: Hamada
  fullname: Hamada, Toshihiro
  organization: Department of Oral Surgery
– sequence: 2
  givenname: Eisaku
  surname: Ueta
  fullname: Ueta, Eisaku
  organization: Department of Oral Surgery
– sequence: 3
  givenname: Hiroyuki
  surname: Kodama
  fullname: Kodama, Hiroyuki
  organization: Department of Chemistry, Kochi Medical School, Kochi, Japan
– sequence: 4
  givenname: Tokio
  surname: Osaki
  fullname: Osaki, Tokio
  organization: Department of Oral Surgery
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13606222$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11896833$$D View this record in MEDLINE/PubMed
BookMark eNqNkV1v0zAUQC00xLrBX0B-gbdk_kji9AWEJjaGBkNoaI_WjXNDb8lHsd2u_fcktGwST3uxZencY8vnhB31Q4-McSlSKbLibJmKucgSlUuVKiFkKsYlT7fP2EwWQiTCyOyIzR6gY3YSwnJkjM7kC3YsZTkvSq1nLN4ukOPWeYw09HxouMPVAjsOfaSKhkgucOrjwAO0tAFO03GDPmC74xDC4Agi1vye4oLHBZLnqxZCB3zlh4jUJxX1NfU_ObhIG4qE4SV73kAb8NVhP2U_Lj7enn9Krm8ur84_XCcu0_k8wSZTRiCWpsxyMDlAVkpZGV3mtWvqrCnAFE2uq1I0SlQud6I0jTBKj3htnD5lb_fe8Sm_1xii7Sg4bFvocVgHa2Q-urQZwdcHcF11WNuVpw78zv77pxF4cwAgOGgbD72j8MjpQhRKqZEr95zzQwgem0dE2CmdXdqpip2q2Cmd_ZvObsfRd_-NOoowVYkeqH2K4P1ecE8t7p58sf18801LocR8NCR7A4WI2wcD-F-2MNrk9u7rpf3-5e7CSGWs1n8A5JLCyg
CitedBy_id crossref_primary_10_3390_ijms25021105
crossref_primary_10_1007_s11095_020_02977_8
crossref_primary_10_1016_j_joms_2013_06_214
crossref_primary_10_1097_j_pain_0000000000000498
crossref_primary_10_5649_jjphcs_37_335
crossref_primary_10_1016_j_joms_2012_01_007
crossref_primary_10_3390_antibiotics11040456
Cites_doi 10.1111/j.1365-2125.1995.tb04479.x
10.1016/0006-2952(81)90151-9
10.1016/S0003-9969(99)00044-8
10.1152/jappl.1975.39.4.519
10.1128/jcm.33.2.432-439.1995
10.1128/IAI.68.2.651-657.2000
10.1093/clinchem/23.2.157
10.1016/S0901-5027(05)80425-4
10.1002/(SICI)1099-081X(199905)20:4<183::AID-BDD178>3.0.CO;2-B
10.1111/j.1600-0714.1996.tb01221.x
10.1016/0378-4347(92)80616-X
10.1111/j.1600-0714.1990.tb00809.x
10.1177/00220345990780030801
10.1097/00000441-199909000-00009
10.2165/00003088-199936060-00006
10.1002/ar.1092210404
10.1016/0306-3623(85)90082-5
10.1016/S0026-895X(25)14597-5
ContentType Journal Article
Copyright 2002 INIST-CNRS
Copyright_xml – notice: 2002 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1046/j.0904-2512.2001.00015.x
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1600-0714
EndPage 116
ExternalDocumentID 11896833
13606222
10_1046_j_0904_2512_2001_00015_x
JOP310209
ark_67375_WNG_RMWF7127_3
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
34H
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAKAS
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CWXXS
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
UDS
V8K
W8V
W99
WBKPD
WBNRW
WIH
WIJ
WIK
WOHZO
WPGGZ
WQJ
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
WRC
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4359-ef4270ee87845a75aa4811b7385dcfd4f6a76f53b80f20bc5c087f072345ad7c3
IEDL.DBID DR2
ISSN 0904-2512
IngestDate Wed Oct 01 14:09:46 EDT 2025
Wed Feb 19 02:08:43 EST 2025
Mon Jul 21 09:15:49 EDT 2025
Wed Oct 01 06:41:32 EDT 2025
Thu Apr 24 22:56:17 EDT 2025
Wed Jan 22 16:27:39 EST 2025
Sun Sep 21 06:18:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Human
High performance
Plasma
Correlation
Excretion
Healthy subject
Rat
Rodentia
Activity
Exploration
Experimental study
Chromatography
Liquid
Binding protein
Vertebrata
Antibiotic
Mammalia
Animal
Clinical trial
Pharmacokinetics
Saliva
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4359-ef4270ee87845a75aa4811b7385dcfd4f6a76f53b80f20bc5c087f072345ad7c3
Notes istex:F01671CD092A4047AD7F5CC94B887FD47D9F0D0F
ArticleID:0015
ark:/67375/WNG-RMWF7127-3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 11896833
PQID 71538537
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_71538537
pubmed_primary_11896833
pascalfrancis_primary_13606222
crossref_primary_10_1046_j_0904_2512_2001_00015_x
crossref_citationtrail_10_1046_j_0904_2512_2001_00015_x
wiley_primary_10_1046_j_0904_2512_2001_00015_x_JOP310209
istex_primary_ark_67375_WNG_RMWF7127_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2002
PublicationDateYYYYMMDD 2002-02-01
PublicationDate_xml – month: 02
  year: 2002
  text: February 2002
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: Denmark
PublicationTitle Journal of oral pathology & medicine
PublicationTitleAlternate J Oral Pathol Med
PublicationYear 2002
Publisher Blackwell Science, Ltd
Blackwell
Publisher_xml – name: Blackwell Science, Ltd
– name: Blackwell
References Briand C, Sarrazin M, Peyrot V, Gilli R, Bourdeaux M, Sari JC. Study of the interaction between human serum albumin and some cephalosporins. Mol Pharmacol 1982; 21: 92-9.
Irwin D, Mande I. The diagnostic uses of saliva. J Oral Pathol Med 1990; 19: 119-25.
Fehske KJ, Muller WE, Wollert U. The location of drug binding sites in human serum albumin. Biochem Pharmacol 1981; 30: 687-92.
Tomita Y, Osaki T. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment. Int J Oral Maxillofac Surg 1990; 19: 299-304.
Fidel PL Jr, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun 2000; 68: 651-7.
Akimoto Y, Nishimura H, Komiya M, et al. Concentrations of ampicillin and cefadroxil in human serum and mixed saliva following a single oral administration of talampicillin and cefadroxil, and relationships between serum and mixed saliva concentrations. Gen Pharmacol 1985; 6: 273-5.
Nauntofte B. Regulation of electrolyte and fluid secretion in salivary acinar cells. Am J Physiol 1992; 263: G823-37.
Schneyer LH, Flatland RF. Evaluation of a reservoir in the main excretory duct of rat submaxillary gland. J Appl Physiol 1975; 39: 519-22.
Turner RJ, Paulais M, Valdez II, Evans RL, Fox PC. Ion transport and signalling in human labial glands. Arch Oral Biol 1999; 44: S15-9.
Schneeberger EE, Lynch RD. Structure, function, regulation of cellular tight junctions. Am J Physiol 1992; 262: L647-61.
Kozjek F, Suturkova LJ, Antolic G, Grabnar I, Mrhar A. Kinetics of 4-fluoroquinolones permeation into saliva. Biopharm Drug Dispos 1999; 20: 183-91.
Horning MG, Brown L, Nowlin J, Lertratanangkoon K, Kellaway P, Zion TE. Use of saliva in therapeutic drug monitoring. Clin Chem 1977; 23: 157-64.
Umazume M, Ueta E, Osaki T. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol 1995; 33: 432-9.
Liu H, Delgado MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet 1999; 36: 453-70.
Dougall HT, Smith L, Duncan C, Benjamin N. The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmacol 1995; 39: 460-2.
Osaki T, Ohshima M, Tomita Y, Matsugi N, Nomura Y. Clinical and physiological investigations in patients with taste abnormality. J Oral Pathol Med 1996; 25: 38-43.
Lotti LV, Hand AR. Endocytosis of parotid salivary proteins by striated duct cells in streptozocin-diabetic rats. Anat Rec 1988; 221: 802-11.
Rudney JD, Hickey KL, Ji Z. Cumulative correlations of lysozome, lactoferrin, peroxidase, S-IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva. J Dent Res 1999; 78: 759-68.
Haeckel R, Hänecke P. Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem 1996; 34: 171-91.
Hamada T, Nakane T, Kimura T, et al. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci 1999; 318: 146-51.
Yamashita K, Motohashi M, Yashiki T. Automated high-perfomance liquid chromatographic method for the simultaneous determination of cefotiam and delta 3-cefotiam in human plasma using column switching. J Chromatogr 1992; 577: 174-9.
1995; 39
1992; 262
1992; 263
2000; 68
1990; 19
1975; 39
1995; 33
1982; 21
1999; 36
1992; 577
1985; 6
1999; 78
1999; 44
1988; 221
1999; 20
1977; 23
1996; 25
1981; 30
1996; 34
1999; 318
e_1_2_5_14_2
e_1_2_5_13_2
e_1_2_5_9_2
e_1_2_5_16_2
Schneeberger EE (e_1_2_5_17_2) 1992; 262
e_1_2_5_15_2
Nauntofte B (e_1_2_5_10_2) 1992; 263
e_1_2_5_22_2
e_1_2_5_6_2
e_1_2_5_5_2
e_1_2_5_20_2
e_1_2_5_4_2
e_1_2_5_11_2
Umazume M (e_1_2_5_2_2) 1995; 33
e_1_2_5_3_2
e_1_2_5_18_2
e_1_2_5_19_2
Haeckel R (e_1_2_5_7_2) 1996; 34
Briand C (e_1_2_5_21_2) 1982; 21
Horning MG (e_1_2_5_8_2) 1977; 23
Schneyer LH (e_1_2_5_12_2) 1975; 39
References_xml – reference: Liu H, Delgado MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet 1999; 36: 453-70.
– reference: Lotti LV, Hand AR. Endocytosis of parotid salivary proteins by striated duct cells in streptozocin-diabetic rats. Anat Rec 1988; 221: 802-11.
– reference: Osaki T, Ohshima M, Tomita Y, Matsugi N, Nomura Y. Clinical and physiological investigations in patients with taste abnormality. J Oral Pathol Med 1996; 25: 38-43.
– reference: Schneeberger EE, Lynch RD. Structure, function, regulation of cellular tight junctions. Am J Physiol 1992; 262: L647-61.
– reference: Rudney JD, Hickey KL, Ji Z. Cumulative correlations of lysozome, lactoferrin, peroxidase, S-IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva. J Dent Res 1999; 78: 759-68.
– reference: Fehske KJ, Muller WE, Wollert U. The location of drug binding sites in human serum albumin. Biochem Pharmacol 1981; 30: 687-92.
– reference: Nauntofte B. Regulation of electrolyte and fluid secretion in salivary acinar cells. Am J Physiol 1992; 263: G823-37.
– reference: Kozjek F, Suturkova LJ, Antolic G, Grabnar I, Mrhar A. Kinetics of 4-fluoroquinolones permeation into saliva. Biopharm Drug Dispos 1999; 20: 183-91.
– reference: Umazume M, Ueta E, Osaki T. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol 1995; 33: 432-9.
– reference: Turner RJ, Paulais M, Valdez II, Evans RL, Fox PC. Ion transport and signalling in human labial glands. Arch Oral Biol 1999; 44: S15-9.
– reference: Tomita Y, Osaki T. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment. Int J Oral Maxillofac Surg 1990; 19: 299-304.
– reference: Fidel PL Jr, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun 2000; 68: 651-7.
– reference: Schneyer LH, Flatland RF. Evaluation of a reservoir in the main excretory duct of rat submaxillary gland. J Appl Physiol 1975; 39: 519-22.
– reference: Akimoto Y, Nishimura H, Komiya M, et al. Concentrations of ampicillin and cefadroxil in human serum and mixed saliva following a single oral administration of talampicillin and cefadroxil, and relationships between serum and mixed saliva concentrations. Gen Pharmacol 1985; 6: 273-5.
– reference: Irwin D, Mande I. The diagnostic uses of saliva. J Oral Pathol Med 1990; 19: 119-25.
– reference: Briand C, Sarrazin M, Peyrot V, Gilli R, Bourdeaux M, Sari JC. Study of the interaction between human serum albumin and some cephalosporins. Mol Pharmacol 1982; 21: 92-9.
– reference: Yamashita K, Motohashi M, Yashiki T. Automated high-perfomance liquid chromatographic method for the simultaneous determination of cefotiam and delta 3-cefotiam in human plasma using column switching. J Chromatogr 1992; 577: 174-9.
– reference: Hamada T, Nakane T, Kimura T, et al. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci 1999; 318: 146-51.
– reference: Horning MG, Brown L, Nowlin J, Lertratanangkoon K, Kellaway P, Zion TE. Use of saliva in therapeutic drug monitoring. Clin Chem 1977; 23: 157-64.
– reference: Haeckel R, Hänecke P. Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem 1996; 34: 171-91.
– reference: Dougall HT, Smith L, Duncan C, Benjamin N. The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmacol 1995; 39: 460-2.
– volume: 36
  start-page: 453
  year: 1999
  end-page: 70
  article-title: Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants
  publication-title: Clin Pharmacokinet
– volume: 34
  start-page: 171
  year: 1996
  end-page: 91
  article-title: Application of saliva for drug monitoring. An in vivo model for transmembrane transport
  publication-title: Eur J Clin Chem Clin Biochem
– volume: 262
  start-page: L647
  year: 1992
  end-page: 61
  article-title: Structure, function, regulation of cellular tight junctions
  publication-title: Am J Physiol
– volume: 263
  start-page: G823
  year: 1992
  end-page: 37
  article-title: Regulation of electrolyte and fluid secretion in salivary acinar cells
  publication-title: Am J Physiol
– volume: 33
  start-page: 432
  year: 1995
  end-page: 9
  article-title: Reduced inhibition of albicans adhesion by saliva from patients receiving oral cancer therapy
  publication-title: J Clin Microbiol
– volume: 25
  start-page: 38
  year: 1996
  end-page: 43
  article-title: Clinical and physiological investigations in patients with taste abnormality
  publication-title: J Oral Pathol Med
– volume: 39
  start-page: 460
  year: 1995
  end-page: 2
  article-title: The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions?
  publication-title: Br J Clin Pharmacol
– volume: 39
  start-page: 519
  year: 1975
  end-page: 22
  article-title: Evaluation of a reservoir in the main excretory duct of rat submaxillary gland
  publication-title: J Appl Physiol
– volume: 68
  start-page: 651
  year: 2000
  end-page: 7
  article-title: Effects of reproductive hormones on experimental vaginal candidiasis
  publication-title: Infect Immun
– volume: 23
  start-page: 157
  year: 1977
  end-page: 64
  article-title: Use of saliva in therapeutic drug monitoring
  publication-title: Clin Chem
– volume: 20
  start-page: 183
  year: 1999
  end-page: 91
  article-title: Kinetics of 4‐fluoroquinolones permeation into saliva
  publication-title: Biopharm Drug Dispos
– volume: 30
  start-page: 687
  year: 1981
  end-page: 92
  article-title: The location of drug binding sites in human serum albumin
  publication-title: Biochem Pharmacol
– volume: 221
  start-page: 802
  year: 1988
  end-page: 11
  article-title: Endocytosis of parotid salivary proteins by striated duct cells in streptozocin‐diabetic rats
  publication-title: Anat Rec
– volume: 6
  start-page: 273
  year: 1985
  end-page: 5
  article-title: Concentrations of ampicillin and cefadroxil in human serum and mixed saliva following a single oral administration of talampicillin and cefadroxil, and relationships between serum and mixed saliva concentrations
  publication-title: Gen Pharmacol
– volume: 78
  start-page: 759
  year: 1999
  end-page: 68
  article-title: Cumulative correlations of lysozome, lactoferrin, peroxidase, S‐IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva
  publication-title: J Dent Res
– volume: 19
  start-page: 299
  year: 1990
  end-page: 304
  article-title: Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment
  publication-title: Int J Oral Maxillofac Surg
– volume: 318
  start-page: 146
  year: 1999
  end-page: 51
  article-title: Treatment of xerostomia with the bile secretion‐stimulating drug anethole trithione: a clinical trial
  publication-title: Am J Med Sci
– volume: 577
  start-page: 174
  year: 1992
  end-page: 9
  article-title: Automated high‐perfomance liquid chromatographic method for the simultaneous determination of cefotiam and delta 3‐cefotiam in human plasma using column switching
  publication-title: J Chromatogr
– volume: 19
  start-page: 119
  year: 1990
  end-page: 25
  article-title: The diagnostic uses of saliva
  publication-title: J Oral Pathol Med
– volume: 21
  start-page: 92
  year: 1982
  end-page: 9
  article-title: Study of the interaction between human serum albumin and some cephalosporins
  publication-title: Mol Pharmacol
– volume: 44
  start-page: S15
  year: 1999
  end-page: 9
  article-title: Ion transport and signalling in human labial glands
  publication-title: Arch Oral Biol
– ident: e_1_2_5_5_2
  doi: 10.1111/j.1365-2125.1995.tb04479.x
– volume: 34
  start-page: 171
  year: 1996
  ident: e_1_2_5_7_2
  article-title: Application of saliva for drug monitoring. An in vivo model for transmembrane transport
  publication-title: Eur J Clin Chem Clin Biochem
– ident: e_1_2_5_20_2
  doi: 10.1016/0006-2952(81)90151-9
– ident: e_1_2_5_9_2
  doi: 10.1016/S0003-9969(99)00044-8
– volume: 39
  start-page: 519
  year: 1975
  ident: e_1_2_5_12_2
  article-title: Evaluation of a reservoir in the main excretory duct of rat submaxillary gland
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1975.39.4.519
– volume: 33
  start-page: 432
  year: 1995
  ident: e_1_2_5_2_2
  article-title: Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy
  publication-title: J Clin Microbiol
  doi: 10.1128/jcm.33.2.432-439.1995
– volume: 263
  start-page: G823
  year: 1992
  ident: e_1_2_5_10_2
  article-title: Regulation of electrolyte and fluid secretion in salivary acinar cells
  publication-title: Am J Physiol
– ident: e_1_2_5_16_2
  doi: 10.1128/IAI.68.2.651-657.2000
– volume: 23
  start-page: 157
  year: 1977
  ident: e_1_2_5_8_2
  article-title: Use of saliva in therapeutic drug monitoring
  publication-title: Clin Chem
  doi: 10.1093/clinchem/23.2.157
– ident: e_1_2_5_11_2
  doi: 10.1016/S0901-5027(05)80425-4
– ident: e_1_2_5_18_2
  doi: 10.1002/(SICI)1099-081X(199905)20:4<183::AID-BDD178>3.0.CO;2-B
– ident: e_1_2_5_15_2
  doi: 10.1111/j.1600-0714.1996.tb01221.x
– ident: e_1_2_5_13_2
  doi: 10.1016/0378-4347(92)80616-X
– volume: 262
  start-page: L647
  year: 1992
  ident: e_1_2_5_17_2
  article-title: Structure, function, regulation of cellular tight junctions
  publication-title: Am J Physiol
– ident: e_1_2_5_14_2
  doi: 10.1111/j.1600-0714.1990.tb00809.x
– ident: e_1_2_5_3_2
  doi: 10.1177/00220345990780030801
– ident: e_1_2_5_4_2
  doi: 10.1097/00000441-199909000-00009
– ident: e_1_2_5_6_2
  doi: 10.2165/00003088-199936060-00006
– ident: e_1_2_5_19_2
  doi: 10.1002/ar.1092210404
– ident: e_1_2_5_22_2
  doi: 10.1016/0306-3623(85)90082-5
– volume: 21
  start-page: 92
  year: 1982
  ident: e_1_2_5_21_2
  article-title: Study of the interaction between human serum albumin and some cephalosporins
  publication-title: Mol Pharmacol
  doi: 10.1016/S0026-895X(25)14597-5
SSID ssj0017341
Score 1.6365092
Snippet Background:  The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many...
Background: The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many...
The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 109
SubjectTerms Adult
Animals
antibiotics
Area Under Curve
Biological and medical sciences
Cefotaxime - administration & dosage
Cefotaxime - blood
Cefotaxime - pharmacokinetics
Cefozopran
Ceftizoxime - administration & dosage
Ceftizoxime - analogs & derivatives
Ceftizoxime - blood
Ceftizoxime - pharmacokinetics
Cephalosporins - administration & dosage
Cephalosporins - blood
Cephalosporins - pharmacokinetics
Chromatography, High Pressure Liquid
Diffusion
excretion
Female
General pharmacology
Humans
Hydrogen-Ion Concentration
Injections, Intravenous
Kinetics
Male
Medical sciences
Perfusion
Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions
Pharmacology. Drug treatments
Protein Binding
protein binding activity
Rats
Rats, Sprague-Dawley
saliva
Saliva - metabolism
Statistics, Nonparametric
Title The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities
URI https://api.istex.fr/ark:/67375/WNG-RMWF7127-3/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.0904-2512.2001.00015.x
https://www.ncbi.nlm.nih.gov/pubmed/11896833
https://www.proquest.com/docview/71538537
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0904-2512
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1600-0714
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017341
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQOcCF9yNAiw-IWyI7dmLniKBLVakFVVTtzbITR0q3TarubrVw4if0N_aXMONkUy3qoULcEiWTx2Sc-eyZ-YaQD2nluXRFBSOtYDFsFbGuMh-rVFc5ePSahQW3vf1851DuHmfHQ_4T1sL0_BDjghuOjPC_xgFuXd-FhAV225OEFUzG6J9xmseTUBacIJ7kIg-zq4ORSYorEZpYjiJDUk8f4Lz9Qmue6j4qfYmZk3YGyqv7rhe3wdJ1lBvc1OQxma5esM9OmSaLuUvKX39xP_4fDTwhjwY0Sz_15veU3PPtM_LgC2YgYRO55-QSzJD6ZYm1kl1Lu5qWmFV2RuGDNq7pkCSaNu28ozOLQSna4C6mivjTn9QOtuMriuvFNEQ16DkA_jNLA8NE017_vnJNKM2hWKNxGRhiX5DDyfaPzzvx0OohLgGvFbGvZaqY91ppmVmVWSs15w6pdqqyrmSdW5XXmXCa1SlzZVYyrcCOUgGnV6oUL8lG27X-NaFOuVxbjHgKC8620lYCSnSiyH0Bh3hE1OqzmnLgQcd2HKcmxOMl1q6hXg3qFbt08hCgz8wyInyUPO-5QO4g8zFYzihgL6aYS6cyc7T_1RzsHU0UT5UREdlaM62bOwiYYwKKi8j7la0Z-AVgXMe2vlvMjEKvlQkVkVe9Cd7Icl3kWsDFdTCkOz-22f32HYB_yoo3_y76ljwMvXNCjvs7sjG_WPhNgHBztxUG5x9h3zXw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtNAEF6h9lAu_EMNtN0D4ubg9a696yOChlCagKpW7W21a68lq6ldNUkVOPEIPCNPwszacRXUQ4W4xUrGdsYznm93Zr4h5E1cOCZsVoCnZVEIn7JQFYkLZayKFCJ6GfkNt_EkHZ2Ig7PkrBsHhL0wLT9Ev-GGnuHf1-jguCH9rktLei-PskiEGKBxnccGvi94AIByU6SwbEGEdNRzSTHJ_RjLXqYr62lTnLefaS1WbaLal1g7aWagvrKde3EbMF3HuT5QDR-S6eovtvUp54PF3A7yH3-xP_4nHTwiDzpAS9-3FviY3HP1E7L1EYuQcI7cU3INlkjdMsd2yaamTUlzLCy7oPBMK1s1yBNNq3re0JnBvBSt8BCrRdz0OzWd-biC4pYx9YkNegmY_8JQTzJR1b9__rKV786h2KZx7Ulin5GT4f7xh1HYTXsIc4BsWehKEcvIOSWVSIxMjBGKMYtsO0VeFqJMjUzLhFsVlXFk8ySPlARTijn8vJA5f0426qZ224RaaVNlMOnJDcTbQhkBQNHyLHUZfMUCIlfPVecdFTpO5Jhqn5IX2L6GetWoVxzUyXyOPtHLgLBe8rKlA7mDzFtvOr2AuTrHcjqZ6NPJJ300Ph1KFkvNA7K7Zls3V-CwzAQgF5C9lbFpeAtgasfUrlnMtMTAlXAZkBetDd7IMpWlisPJlbekO9-2Pvj6DbB_HGUv_110j2yNjseH-vDz5Msrct-P0vEl76_Jxvxq4XYA0c3trvfUP9C4OhE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELfQJgEv_GcExuYHxFtKnNix_YgoZQxWpolpe7Ps2JGidUm1tlPhiY_AZ-STzOekmYr2MCHeUqWXppe73M--u98h9Ca1jlAjrfc0mcT-SMbCMhfzVNjcR_QyCRtuB-N875jun7LTbhwQ9MK0_BD9hht4Rnhfg4O7qS3fdWnJ4OWJTGgMARrWeWQQ-oIHHlBuUiYF1PcNj3ouKcKzMMayl-nKetoU581XWotVm6D2JdRO6plXX9nOvbgJmK7j3BCoRg_RZPUX2_qUs8FibgbFz7_YH_-TDh6hBx2gxe9bC3yM7rj6Cbo3hCIkmCP3FF16S8RuWUC7ZFPjpsQFFJadY_9MK1M1wBONq3re4JmGvBSu4CNUi7jJD6w783EWw5YxDokNPPWY_1zjQDJR1X9-_TZV6M7B0KZxGUhin6Hj0cfvH_bibtpDXHjIJmNX0pQnzgkuKNOcaU0FIQbYdmxRWlrmmucly4xIyjQxBSsSwb0ppZn_uuVF9hxt1E3tXiBsuMmFhqRnpn28tUJTDxRNJnMn_SkSIb56rqroqNBhIsdEhZQ8hfY10KsCvcKgThJy9EwtI0R6yWlLB3ILmbfBdHoBfXEG5XScqZPxJ3V0cDLiJOUqi9DOmm1d_0Lml5keyEVod2Vsyr8FILWja9csZopD4GIZj9BWa4PXskTIXGT-4iJY0q1vW-1_O_TYP03ky38X3UV3D4cj9fXz-MsrdD9M0gkV79toY36xcK89oJubneCoVyiMOZU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+excretion+of+cephem+antibiotics+into+saliva+is+inversely+associated+with+their+plasma+protein%E2%80%90binding+activities&rft.jtitle=Journal+of+oral+pathology+%26+medicine&rft.au=Hamada%2C+Toshihiro&rft.au=Ueta%2C+Eisaku&rft.au=Kodama%2C+Hiroyuki&rft.au=Osaki%2C+Tokio&rft.date=2002-02-01&rft.issn=0904-2512&rft.eissn=1600-0714&rft.volume=31&rft.issue=2&rft.spage=109&rft.epage=116&rft_id=info:doi/10.1046%2Fj.0904-2512.2001.00015.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1046_j_0904_2512_2001_00015_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0904-2512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0904-2512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0904-2512&client=summon